X4 Pharmaceuticals, Inc.
Compositions of CXCR4 inhibitors and methods of preparation and use

Last updated:

Abstract:

The present invention provides compositions and methods of use for treating, preventing, or ameliorating a disease, disorder, or condition associated with a chemokine receptor such as CXCR4.

Status:
Grant
Type:

Utility

Filling date:

11 Dec 2018

Issue date:

4 Feb 2020